Literature DB >> 21702857

Regulation of pre-adipocyte proliferation and apoptosis by the small leucine-rich proteoglycans, biglycan and decorin.

M Ward1, K M Ajuwon.   

Abstract

Evidence for a functional role for extracellular matrix (ECM) proteins in adipose tissue is demonstrated in dynamic changes in expression of ECM genes during adipocyte differentiation and in obesity. Components of the ECM may regulate adipose cell number expansion by restricting pre-adipocyte proliferation, regulating apoptosis and inhibiting adipogenesis. Although pre-adipocytes express multiple proteoglycans, their role in pre-adipocyte proliferation up to now has remained unknown. The study described here was conducted to characterize roles of small leucine-rich proteoglycans (SLRPs) in adipocyte proliferation. Pre-adipocytes were seeded on plates coated with biglycan and decorin and were allowed to differentiate. In addition, pre-adipocytes were incubated on plates coated with biglycan, decorin, or fibronectin and measurements were made of cell proliferation and apoptosis. We are able to report that SLRPs decorin and biglycan did not affect differentiation of our 3T3-L1 cells; however, biglycan and decorin did reduce proliferation of pre-adipocytes, partly by induction of apoptosis. Furthermore, anti-proliferative capabilities of decorin and biglycan were nullified with removal of GAG side-chains suggesting that the chains played key roles in anti-proliferative effects of the SLRPs. We also found that co-treatment of decorin or biglycan with the proteoglycan fibronectin restored normal proliferation, an indication that multiple ECM proteins may act in concert to regulate overall proliferation rates of pre-adipocytes. These studies indicate that SLRPs may compose a regulatory factor in adipose tissue expansion, through hyperplasia.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21702857      PMCID: PMC6496550          DOI: 10.1111/j.1365-2184.2011.00763.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  34 in total

1.  The expression of adipogenic genes is decreased in obesity and diabetes mellitus.

Authors:  S T Nadler; J P Stoehr; K L Schueler; G Tanimoto; B S Yandell; A D Attie
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

Review 2.  Adipocyte differentiation from the inside out.

Authors:  Evan D Rosen; Ormond A MacDougald
Journal:  Nat Rev Mol Cell Biol       Date:  2006-12       Impact factor: 94.444

3.  Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases.

Authors:  M Santra; D M Mann; E W Mercer; T Skorski; B Calabretta; R V Iozzo
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

4.  Weight reduction modulates expression of genes involved in extracellular matrix and cell death: the GENOBIN study.

Authors:  M Kolehmainen; T Salopuro; U S Schwab; J Kekäläinen; P Kallio; D E Laaksonen; L Pulkkinen; V I Lindi; K Sivenius; U Mager; N Siitonen; L Niskanen; H Gylling; R Rauramaa; M Uusitupa
Journal:  Int J Obes (Lond)       Date:  2007-09-11       Impact factor: 5.095

5.  Human adipose tissue is a source of multipotent stem cells.

Authors:  Patricia A Zuk; Min Zhu; Peter Ashjian; Daniel A De Ugarte; Jerry I Huang; Hiroshi Mizuno; Zeni C Alfonso; John K Fraser; Prosper Benhaim; Marc H Hedrick
Journal:  Mol Biol Cell       Date:  2002-12       Impact factor: 4.138

6.  TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB.

Authors:  C Y Wang; M W Mayo; A S Baldwin
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

7.  Fibronectin modulation of cell shape and lipogenic gene expression in 3T3-adipocytes.

Authors:  B M Spiegelman; C A Ginty
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

8.  Decorin is a secreted protein associated with obesity and type 2 diabetes.

Authors:  K Bolton; D Segal; J McMillan; J Jowett; L Heilbronn; K Abberton; P Zimmet; D Chisholm; G Collier; K Walder
Journal:  Int J Obes (Lond)       Date:  2008-04-15       Impact factor: 5.095

Review 9.  Cyclin D1: polymorphism, aberrant splicing and cancer risk.

Authors:  K E Knudsen; J Alan Diehl; C A Haiman; E S Knudsen
Journal:  Oncogene       Date:  2006-03-13       Impact factor: 9.867

10.  Effects of decorin and biglycan on human airway smooth muscle cell proliferation and apoptosis.

Authors:  Michelle L D'Antoni; Chiara Torregiani; Pasquale Ferraro; Marie-Claire Michoud; Bruce Mazer; James G Martin; Mara S Ludwig
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-02-01       Impact factor: 5.464

View more
  14 in total

Review 1.  Fat deposition and accumulation in the damaged and inflamed skeletal muscle: cellular and molecular players.

Authors:  Clara Sciorati; Emilio Clementi; Angelo A Manfredi; Patrizia Rovere-Querini
Journal:  Cell Mol Life Sci       Date:  2015-02-18       Impact factor: 9.261

Review 2.  Environmental preconditioning rejuvenates adult stem cells' proliferation and chondrogenic potential.

Authors:  Ming Pei
Journal:  Biomaterials       Date:  2016-11-25       Impact factor: 12.479

Review 3.  Insights into the key roles of proteoglycans in breast cancer biology and translational medicine.

Authors:  Achilleas D Theocharis; Spyros S Skandalis; Thomas Neill; Hinke A B Multhaupt; Mario Hubo; Helena Frey; Sandeep Gopal; Angélica Gomes; Nikos Afratis; Hooi Ching Lim; John R Couchman; Jorge Filmus; Ralph D Sanderson; Liliana Schaefer; Renato V Iozzo; Nikos K Karamanos
Journal:  Biochim Biophys Acta       Date:  2015-03-28

4.  Decreased body fat, elevated plasma transforming growth factor-β levels, and impaired BMP4-like signaling in biglycan-deficient mice.

Authors:  Tao Tang; Joel C Thompson; Patricia G Wilson; Christina Nelson; Kevin Jon Williams; Lisa R Tannock
Journal:  Connect Tissue Res       Date:  2012-08-23       Impact factor: 3.417

5.  Lentiviral delivery of biglycan promotes proliferation and increases osteogenic potential of bone marrow-derived mesenchymal stem cells in vitro.

Authors:  Bo Wu; Xu Ma; Damu Zhu; Ye Liu; Zhuqing Sun; Suyuan Liu; Bing Xue; Mingchang Du; Ximeng Yin
Journal:  J Mol Histol       Date:  2013-03-17       Impact factor: 2.611

Review 6.  Psammomys obesus: a Natural Diet-Controlled Model for Diabetes and Cardiovascular Diseases.

Authors:  Rajneesh Chaudhary; Ken R Walder; Christoph E Hagemeyer; Jagat R Kanwar
Journal:  Curr Atheroscler Rep       Date:  2018-07-17       Impact factor: 5.113

7.  Adipose tissue biglycan as a potential anti-inflammatory target of sodium salicylate in mice fed a high fat diet.

Authors:  Venkata J Adapala; Meliza Ward; Kolapo M Ajuwon
Journal:  J Inflamm (Lond)       Date:  2012-04-25       Impact factor: 4.981

8.  The small leucine-rich proteoglycan, biglycan, is highly expressed in adipose tissue of Psammomys obesus and is associated with obesity and type 2 diabetes.

Authors:  Kristy Bolton; David Segal; Ken Walder
Journal:  Biologics       Date:  2012-04-02

9.  Diphlorethohydroxycarmalol of Ishige okamurae and Caffeine Modified the Expression of Extracellular Fibrillars during Adipogenesis of Mouse Subcutaneous Adipose Derived Stem Cell.

Authors:  Younmi Jeon; Siyoung Song; Hagju Kim; Yong-Pil Cheon
Journal:  Dev Reprod       Date:  2013-09

10.  Biglycan deletion alters adiponectin expression in murine adipose tissue and 3T3-L1 adipocytes.

Authors:  Meliza G Ward; Kolapo M Ajuwon
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.